|
Shinva Medical Instrument Co., Ltd. (600587.SS) DCF -Bewertung
CN | Healthcare | Medical - Devices | SHH
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Shinva Medical Instrument Co., Ltd. (600587.SS) Bundle
Vereinfachen Sie die Bewertung von Shinva Medical Instrument Co., Ltd. (600587) mit diesem anpassbaren DCF -Taschenrechner! Mit Real Shinva Medical Instrument Co., Ltd. (600587) Finanzdaten und einstellbaren Prognoseeingängen können Sie Szenarien testen und Shinva Medical Instrument Co., Ltd. (600587S) beizulegen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,766.8 | 9,151.0 | 9,482.2 | 9,281.8 | 10,011.9 | 10,356.1 | 10,712.2 | 11,080.6 | 11,461.6 | 11,855.7 |
| Revenue Growth, % | 0 | 4.38 | 3.62 | -2.11 | 7.87 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 |
| EBITDA | 1,476.5 | 661.8 | 1,024.3 | 830.4 | 967.7 | 1,107.9 | 1,146.0 | 1,185.4 | 1,226.1 | 1,268.3 |
| EBITDA, % | 16.84 | 7.23 | 10.8 | 8.95 | 9.67 | 10.7 | 10.7 | 10.7 | 10.7 | 10.7 |
| Depreciation | 230.1 | 224.7 | 249.1 | 241.1 | 213.2 | 257.5 | 266.4 | 275.5 | 285.0 | 294.8 |
| Depreciation, % | 2.62 | 2.46 | 2.63 | 2.6 | 2.13 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 |
| EBIT | 1,246.5 | 437.1 | 775.2 | 589.2 | 754.5 | 850.3 | 879.6 | 909.8 | 941.1 | 973.5 |
| EBIT, % | 14.22 | 4.78 | 8.18 | 6.35 | 7.54 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 |
| Total Cash | 1,147.2 | 1,392.4 | 1,665.3 | 1,789.4 | 3,288.4 | 2,029.5 | 2,099.3 | 2,171.5 | 2,246.2 | 2,323.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,931.5 | 1,751.2 | 1,771.7 | 2,003.9 | 2,109.5 | 2,123.3 | 2,196.3 | 2,271.8 | 2,349.9 | 2,430.7 |
| Account Receivables, % | 22.03 | 19.14 | 18.68 | 21.59 | 21.07 | 20.5 | 20.5 | 20.5 | 20.5 | 20.5 |
| Inventories | 2,152.6 | 2,342.3 | 2,305.7 | 3,028.7 | 3,555.8 | 2,953.9 | 3,055.4 | 3,160.5 | 3,269.2 | 3,381.6 |
| Inventories, % | 24.55 | 25.6 | 24.32 | 32.63 | 35.52 | 28.52 | 28.52 | 28.52 | 28.52 | 28.52 |
| Accounts Payable | 1,837.7 | 1,287.1 | 2,192.7 | 2,496.9 | 2,443.3 | 2,267.1 | 2,345.1 | 2,425.7 | 2,509.1 | 2,595.4 |
| Accounts Payable, % | 20.96 | 14.07 | 23.12 | 26.9 | 24.4 | 21.89 | 21.89 | 21.89 | 21.89 | 21.89 |
| Capital Expenditure | -215.8 | -191.3 | -274.4 | -247.6 | -535.8 | -320.3 | -331.3 | -342.7 | -354.5 | -366.7 |
| Capital Expenditure, % | -2.46 | -2.09 | -2.89 | -2.67 | -5.35 | -3.09 | -3.09 | -3.09 | -3.09 | -3.09 |
| Tax Rate, % | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 |
| EBITAT | 958.0 | 296.4 | 600.8 | 511.5 | 668.1 | 676.1 | 699.3 | 723.4 | 748.2 | 774.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1,274.2 | -230.2 | 1,497.3 | -145.9 | -340.8 | 1,025.3 | 537.8 | 556.2 | 575.4 | 595.2 |
| WACC, % | 5.04 | 5 | 5.04 | 5.08 | 5.09 | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2,880.7 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 613 | |||||||||
| Terminal Value | 29,895 | |||||||||
| Present Terminal Value | 23,367 | |||||||||
| Enterprise Value | 26,248 | |||||||||
| Net Debt | -2,110 | |||||||||
| Equity Value | 28,358 | |||||||||
| Diluted Shares Outstanding, MM | 595 | |||||||||
| Equity Value Per Share | 47.70 |
What You Will Receive
- Authentic Shinva Data: Preloaded financials – encompassing revenue to EBIT – based on actual and forecasted figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess the impact of changes on Shinva’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and detailed forecasting.
- Efficient and Precise: Bypass the challenges of building models from scratch while ensuring accuracy and adaptability.
Key Features
- Current Shinva Medical Data: Pre-loaded with Shinva Medical Instrument Co., Ltd.’s historical financial performance and forward-looking estimates.
- Comprehensive Input Customization: Tailor revenue growth, profit margins, WACC, tax rates, and capital expenditures as per your analysis.
- Responsive Valuation Framework: Automatic recalibration of Net Present Value (NPV) and intrinsic value based on user-defined inputs.
- Multi-Scenario Analysis: Develop various forecasting scenarios to explore diverse valuation possibilities.
- Intuitive User Interface: Designed for ease of use, catering to both industry experts and novices.
How It Works
- Download the Template: Gain immediate access to the Excel-based Shinva Medical DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh to reflect Shinva Medical’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial strategies.
Why Choose Shinva's Medical Calculator?
- All-in-One Solution: Offers a comprehensive suite including DCF, WACC, and financial ratio evaluations tailored for healthcare.
- Flexible Inputs: Modify the highlighted fields to explore different financial scenarios.
- In-Depth Analysis: Automatically determines the intrinsic value and Net Present Value specific to Shinva Medical Instrument Co., Ltd. (600587SS).
- Pre-Existing Data: Comes with historical and projected data for reliable calculations.
- High Standards: Perfectly suited for financial analysts, healthcare investors, and industry consultants.
Who Should Use This Product?
- Individual Investors: Gain insights to make well-informed decisions when buying or selling Shinva Medical Instrument Co., Ltd. (600587SS) shares.
- Financial Analysts: Optimize valuation approaches with easy-to-use financial models tailored for Shinva Medical Instrument Co., Ltd. (600587SS).
- Consultants: Provide clients with accurate and timely valuation insights regarding Shinva Medical Instrument Co., Ltd. (600587SS).
- Business Owners: Learn how major companies like Shinva Medical Instrument Co., Ltd. (600587SS) are valued to inform your own business strategies.
- Finance Students: Master valuation techniques with hands-on experience using real data from Shinva Medical Instrument Co., Ltd. (600587SS).
What the Template Includes
- Pre-Filled DCF Model: Shinva Medical's financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Shinva Medical’s profitability, leverage, and operational efficiency.
- Editable Inputs: Adjust assumptions such as growth rates, profit margins, and capital expenditures for tailored scenarios.
- Financial Statements: Annual and quarterly reports for in-depth financial scrutiny.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.